TARA
Protara Therapeutics, Inc.Closed2.62−0.15 −5.42%USD
NasdaqGM · as of Oct 13, 16:00 ET · 15m delayAfter hours 2.62 0.00%
Open
2.77
Prev close
2.77
Day range
2.622.83
52-week range
2.517.82
Volume
930.19K1.13×
Mkt cap
154.83M
P/E ttm
—
Fwd P/E
-1.55
EPS ttm
-1.36
Div yield
0.00%
Earnings
Aug 11, 2026
From 52w high
−66.50%
TARA earnings and estimates
TARA Next Report
Yahoo Finance · Nasdaq
Report date
Tue, Nov 10
Before the open · estimated
EPS consensus
$−0.36
range −0.38 – −0.34
EPS growth vs year ago
−17.1%
year ago −0.31
Revenue consensus
$0
0.0% vs year ago
Options-implied move
±18.7%
by Nov 20 · ATM straddle
Past 4 reactions
±3.0%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 11, 2026 BMO | −0.36 | −0.31 | −14.64% | $0 | −4.9% | −3.2% |
| Mar '26 | May 13, 2026 BMO | −0.31 | −0.37 | +15.64% | $0 | +1.0% | −15.7% |
| Dec '25 | Mar 10, 2026 BMO | −0.38 | −0.31 | −21.81% | $0 | −0.7% | −5.7% |
| Sep '25 | Nov 10, 2025 BMO | −0.31 | −0.39 | +19.48% | $0 | +5.6% | +28.4% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.36 | −0.38−0.34 | −17.1% | $0 | 0.0% | −0.36 0.0% | −0.33 −9.7% | 0 / 3 |
| Next quarter Dec 2026 | −0.38 | −0.41−0.35 | +0.9% | $0 | 0.0% | −0.38 0.0% | −0.34 −9.5% | 2 / 3 |
| Current year Dec 2026 | −1.39 | −1.46−1.31 | −4.0% | $0 | 0.0% | −1.39 0.0% | −1.39 −0.4% | 0 / 5 |
| Next year Dec 2027 | −1.69 | −2.25−1.13 | −21.4% | $1.00M | 0.0% | −1.69 0.0% | −1.64 −2.9% | 1 / 3 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.37 | −0.38−0.36 | 4 | 0 / 0 |
| Dec 2026 | −0.38 | −0.41−0.36 | 4 | 0 / 0 |
| Mar 2027 | −0.42 | −0.46−0.38 | 2 | 0 / 0 |
| Jun 2027 | −0.44 | −0.49−0.39 | 2 | 0 / 0 |
| Sep 2027 | −0.40 | −0.40−0.39 | 2 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −1.40 | −1.46−1.31 | 5 | 0 / 0 |
| Dec 2027 | −1.69 | −2.14−1.38 | 5 | 0 / 0 |
| Dec 2028 | −1.11 | −2.13−0.43 | 3 | 0 / 0 |
| Dec 2029 | 0.42 | 0.270.56 | 2 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.